Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
1020 First Avenue King of Prussia, PA 19406 US
CSL Behring, a Business Unit of CSL, is a global biotherapeutics leader driven by its promise to save lives.
Headcount: 24,660 Revenues: $13,310 (+31%) Net Income: $7,250 (+32%) R&D: $1,232 (+22%)
Melbourne, Australia-based CSL develops and delivers innovative medicines that help people with serious and life-threatening conditions through three businesses: CSL Behring, a global biotherapeutics leader; CSL Seqirus, a leading influenza vaccine provider; and the recently acquired CSL Vifor, a global partner for pharmaceuticals and innovative therapies in iron deficiency and nephrology.
Revenue for fiscal year 2023 was $13.31 billion, up 31% when compared to the prior comparable period, delivered against a challenging operating environment. In particular, the CSL Behring business rebounded strongly driven by growth in immunoglobulin sales and record plasma collections.
Early 2023 was marked by a major leadership transition as Paul Perreault retired from his role as CEO and managing director after 10 years in the position. Dr. Paul McKenzie was appointed as the new chief executive and managing director in March 2023, bringing more than 30 years of leadership experience in the global biotechnology industry, including his time at CSL as the chief operating officer.
In March 2023, CSL celebrated the opening of a new plasma fractionation facility in Marburg, Germany, a $470 million project that took five years to construct. With optimized process flows, modern technologies and automation, the new fractionation facility quadruples the current capacity.
In June 2023, the first patient received FDA approved gene therapy Hemgenix for hemophilia B in the U.S. In March 2024, the FDA approved Vafseo tablets for the treatment of anemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at least three months.
Most recently, in June, CSL Seqirus was selected by the Health Emergency Preparedness and Response Authority (HERA), part of the European Commission (EC), to provide 665,000 pre-pandemic vaccine doses for fifteen EU and EEA member states as well as to the “Union Civil Protection Mechanism.”
Headcount: 25,000 Revenues: $8,951 Net Income: $2,117 R&D: $857 *CSL does not report annual results until 30 June, so data is estimated.
TOP SELLING DRUGS
Headcount: 10,500 Bio/Pharma Revenue: $4,550 (10%) Total Revenues: $4,747 (11%) Net Income: $1,009 (8%) R&D Budget: $364 (13%)
Top Selling Drugs
Account for 61% of total biopharma sales, down from 63% in previous year.
NOTE: Fiscal year ends June 30, so these results are based on previous fiscal year, ending June 30, 2011
NOTE: Australian dollar appreciated 4% from year to year, creating jumps in results in USD
Headcount: 10,000 Pharma Revenues: $3,930 (23%/4%*) Total Revenues: $4,082 (8%/-8%*) Net Income: $929 (8%/-8%*) R&D Budget: $280 (20%/2%*)
* Converted at avg. exch. rate / based on reported currency (AUD)
Fiscal year ends June 30, so these results are based on previous fiscal year, ending June 30, 2010
Australian dollar appreciated 17% from year to year, creating extreme jumps in results in USD
Top-Selling Drugs in 2010
Drug
Indication
(+/- %)
Immunoglobulins
$1,049
9%
Plasma-derived coagulants
Helixate/Recombinant FVIII
Albumin
$309
n/a
Account for 56% of total biopharma sales, same as previous year..
Previous Profile: Biogen Idec. // Next Profile: Genzyme
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !